Xcout Intel
Nasus Pharma Ltd.
Nasus Pharma Ltd. is an Israeli biotechnology corporation founded in 2019 and based in Tel Aviv-Yafo, Israel. The company focuses on the development of novel medical treatments and powder-based nasal spray products.
Subscribe to see Nasus Pharma Ltd.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Nasus Pharma Ltd. at a glance
Nasus Pharma Ltd. is a biotech company headquartered in Tel Aviv, Israel, founded in 2019. It is publicly listed (NSRX) with a market capitalisation of $44.2M. Xcout tracks 24 named people at Nasus Pharma Ltd., including BRENDAN O'GRADY (Chief Executive Officer & Director).
Nasus Pharma Ltd. leadership
- BRENDAN O'GRADYChief Executive Officer & Director
- Eyal RubinCFO & Executive VP
- Oren ElmaliachDirector of Finance & Interim CFO
- Dalia MegiddoCo-Founder, Director, Chief Medical Officer & Chief Development Officer?
- Dr. Dalia MegiddoCo-founder, Board Member, Chief Development Officer
- Ehud Moshe GilboaCo-Founder & Executive Chairman
18 more named people on record for Nasus Pharma Ltd., with roles, board committees and tenure — see the full roster →
Nasus Pharma Ltd. competitors
A few of Nasus Pharma Ltd.'s closest competitors — see the full list of competitors and alternatives →
PsyRX CNS Bio-Tech Ltd is dedicated to developing cannabinoid-based pharmaceuticals and healthcare products. Its portfolio encompasses drugs targeting diverse medical conditions, personalized cannabinoid formulations, and CBD-infused skincare along with food supplements. Established in 2019, the company, formerly known as Cannabotech LTD, is headquartered in Rishon LeZion, Israel.
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from its headquarters in Ra'anana, Israel.
Syremis Therapeutics Ltd. is a clinical-stage biopharmaceutical company headquartered in Tel Aviv, Israel, dedicated to developing novel drug pipeline medicines targeted at treating diseases of the nervous system and mental health disorders.
NeuroDerm is an R&D company based in Rehovot, Israel, that focuses on healthcare innovation. It integrates pharmaceutical and medical technology solutions to provide patient-centric treatments.
Phoreus Biotechnology, Inc. is a privately held biotechnology company founded in 2018 and headquartered in Olathe, Kansas. The company specializes in the development of proprietary nanocarriers for targeted drug delivery and enhanced treatments.
ProteKt Therapeutics is a biotechnology company founded in 2014 and headquartered in Beni-Brak, Israel, that develops novel therapeutics focusing on the nervous system and cellular protection.
Get Nasus Pharma Ltd.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Nasus Pharma Ltd. in Xcout Intel
- 24 named people with titles, LinkedIn and board committees
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access